Pancreatic Cancer Research

ResearcherThe University of Texas Southwestern Medical CenterNo recent work listed

Kathleen F. Ludwig

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-4791-2749; OpenAlex author ID A5002307364. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper

Papers 2

  1. Small-Molecule Inhibition of Axl Targets Tumor Immune Suppression and Enhances Chemotherapy in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-17-1973↗
  2. Warfarin Blocks Gas6-Mediated Axl Activation Required for Pancreatic Cancer Epithelial Plasticity and Metastasis. First author DOI 10.1158/0008-5472.can-14-2887-t↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Noah B. Sorrelle · 2 shared papers, 2015–2018 · strength 0.12
  2. Rolf A. Brekken · 2 shared papers, 2015–2018 · strength 0.12
  3. Shinichi Yabuuchi · 1 shared paper, 2018 · strength 0.07
  4. Victoria H. Cruz · 1 shared paper, 2018 · strength 0.07
  5. Mary Topalovski · 1 shared paper, 2018 · strength 0.07
  6. N.V. Rajeshkumar · 1 shared paper, 2018 · strength 0.07
  7. Wenting Du · 1 shared paper, 2018 · strength 0.07
  8. Anirban Maitra · 1 shared paper, 2018 · strength 0.07
  9. Miao Wang · 1 shared paper, 2015 · strength 0.04
  10. Amanda Kirane · 1 shared paper, 2015 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.